Clinical Trials

Study Title:
A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined with Pemetrexed and Carboplatin in Patients with EGFRmutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment (HARMONi)

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Mariam Alexander, at alexanma@musc.edu. Study Coordinator, Jessica Shealor, at shealorj@musc.edu. Trial opened at the following institutions: Medical University of South Carolina